Creating Value with Hub Models: Part 2 - Outcomes for All
By Lash Group |
Advantages for patients
One inherent benefit of the hub model is that messaging and communication come from one source – it’s a durable approach that lets manufacturers stay on top of the messaging from the decision to treat to the time therapy is complete. Lash Group has highly skilled associates who provide end-to-end, personalized management directly through the hub, rather than acting as a triage to get the patient to a solution. The hub serves as a single point of contact where patients can get answers to any questions, thereby improving the patient experience and perception of the product and care.
The biggest driver in making the hub model work for patients at Lash Group is our patients first service philosophy, which ensures that your patients always have an experience that assures ongoing trust in your brand and support throughout the duration of therapy. This philosophy means that Lash Group applies best-in-class technology and proven program performance indicators to ensure that patients not only experience program effectiveness, but also quality of service.
Adapting to the prescriber workflow
Lash Group's infrastructure includes both relationships with suppliers and forward-looking technology. The flexibility of our technology and program design capabilities, based on years of experience in designing these programs, allows us to create a solution that fits multiple players within the industry. And our relationship with our sister companies allows us to adopt those changes more quickly and respond to manufacturer needs more efficiently by leveraging the vast resources of AmerisourceBergen. Most of all, flexibility means the ability to design programs that produce outcomes others cannot. As more and more prescribers look to hub models as a way to collaborate in patient care, the flexibility to integrate with the prescriber workflow will be critical.
Outcomes: Proven results
There’s more to the hub model than patient and provider education and communication. Lash Group data demonstrates that addressing multiple access barriers through one solution can lead to improved product outcomes. Moreover, single solutions (e.g., copay support, clinical adherence) are most likely to incrementally improve outcomes; however, when strategically packaged, outcomes are even better. When the program primarily serves as a support mechanism to address patients and HCPs as needs arise, the strategic positioning and subsequent marketing of the program/hub can impact services and utilization significantly. In fact, when combined with specialty pharmacy, the hub model can increase duration of therapy as much as 25 percent. For example, one manufacturer had multiple optional support offerings, strategically packaging the services showed an improvement in Medication Possession Ratio as compared to the product baseline.